Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
374M
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
46.5M
-
Shares change
-
-696K
-
Total reported value, excl. options
-
$54.4M
-
Value change
-
-$780K
-
Put/Call ratio
-
1.65
-
Number of buys
-
29
-
Number of sells
-
-28
-
Price
-
$1.17
Significant Holders of STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB) as of Q4 2022
77 filings reported holding LAB - STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share as of Q4 2022.
STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46.5M shares
of 374M outstanding shares and own 12.42% of the company stock.
Largest 10 shareholders include Caligan Partners LP (8.58M shares), Indaba Capital Management, L.P. (7.45M shares), PRIMECAP MANAGEMENT CO/CA/ (4.62M shares), Neuberger Berman Group LLC (4.35M shares), VANGUARD GROUP INC (3.96M shares), NEEDHAM INVESTMENT MANAGEMENT LLC (3.8M shares), MORGAN STANLEY (3.06M shares), BOOTHBAY FUND MANAGEMENT, LLC (2.3M shares), BlackRock Inc. (1.41M shares), and Price Jennifer C. (973K shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.